Willingness to pay in treatment of bleeding disorders

International Journal of Technology Assessment in Health Care

Volumn 16, Issue 2, 2000, Pages 706-710

  Eastaugh, Steven R ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLEEDING DISORDER; EDUCATION; FEMALE; HEALTH STATUS; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PREDICTION; RATING SCALE; REVIEW; VON WILLEBRAND DISEASE;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; FEES, PHARMACEUTICAL; FEMALE; FINANCING, PERSONAL; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES; VON WILLEBRAND DISEASE;

EID: 0033858855     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300101266     Document Type: Review

References (14)

1. Chestnut, L., Keller, R., & Lambert, W. Measuring heart patients' willingness to pay for changes in angina symptoms. Medical Decision Making, 1996, 16, 65-77.
2. Duan, N. Smearing estimate: A nonparametric retransformation method. Journal of the American Statistical Association, 1983, 78, 605-10.
3. Eastaugh, S. Valuation of the benefits of risk-free blood: Willingness to pay for solutions. International Journal of Technology Assessment in Health Care, 1991, 7, 51-59.
4. Eastaugh, S. Health economics: Efficiency, quality and equity. Westport, CT: Greenwood, 1993.
5. Eastaugh, S. Health care finance: Cost, productivity and strategic design, Gaithersburg, MD: Aspen, 1999.
6. Johannesson, M., Johansson, P., & Kristrom, B. Willingness to pay for antihypertensive therapy. Journal of Health Economics, 1993, 12, 95-108.
7. Lindholm, L., Rosen, M., & Hellsten, G. Are people willing to pay for community-based preventive programs. International Journal of Technology Assessment in Health Care, 1994, 10, 317-24.
8. Mannucci, P. Treatment of von Willebrand's disease. Journal of Internal Medicine, 1997, 740 (suppl.), 129-32.
9. National Oceanic and Atmospheric Administration. Natural resource damage assessments: Proposed rules. Federal Register, 1994, 59, 1062-91.
10. Nichols, W., & Ginsburg, D. Von Willebrand's disease. Medicine (Baltimore), 1997, 76, 1-20.
11. Ramsey, S., Sullivan, S., Psaty, B., et al. Willingness to pay for antihypertensive care: Evidence from a staff model HMO. Social Science and Medicine, 1997, 44, 1911-17.
12. Scott, J., & Huskisson, E. Measurement of functional capacity with visual analogue scales. Rheumatology Rehabilitation, 1977, 16, 257-59.
13. Voelker, R. New focus on von Willebrand's disease. JAMA, 1997, 278, 1137-38.
14. Zethraeus, N., Johannesson, M., & Henriksson, P. Impact of hormone replacement therapy on quality of life and willingness to pay. British Journal of Obstetrics and Gynecology, 1997, 104, 1191-95.